Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 3
1(50.0%)
2Total
N/A(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04341545Phase 3Unknown

Letrozole in Tubal Ectopic Pregnancy

Role: collaborator

NCT03982914Unknown

The Use of HE4 With Simple Ultrasound Rules to Predict Malignancy in a Pelvic Mass

Role: collaborator

NCT04892979Not ApplicableUnknown

3R Rehabilitation Management of COVID-19 Survivors

Role: collaborator

All 3 trials loaded